跳至主要内容
临床试验/NCT06462742
NCT06462742招募中不适用

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma Within Milan Criteria

Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Disease-free survival

研究概览

简要总结

Thermal ablation has been recommended by worldwide guidelines as first-line treatment for hepatocellular carcinoma (HCC), while evidence regarding its efficacy for primary intrahepatic cholangiocarcinoma (iCCA) is lacking. The goal of this observational study is to study the efficacy of ablation in treating iCCA by comparing its prognosis with surgery. The main questions it aims to answer are:

  • Whether microwave ablation could achieve similar efficacy with liver resection in treating iCCA
  • What is the risk factor for ablation or surgery in treating iCCA
  • What kind of iCCA patients could receive ablation as their first-line treatment In this real-world multicenter cohort study, we will collect data of iCCA patients from hospitals who underwent microwave ablation (MWA) or liver resection (LR) for tumors within Milan criteria. Survival will be compared between patients treated by MWA or LR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pathologically diagnosed iCCA based on the WHO classifications;
  • curative-intent liver resection or microwave ablation;
  • tumor within Milan criteria, namely single tumor ≤5cm in maximum diameter; multiple tumors ≤3 in number and each ≤3cm; no evidence of major vascular/hilar invasion, extrahepatic/lymphatic metastasis or other malignancies;
  • age ≥18 years.

排除标准

  • Patients not meeting any one of the inclusion criteria were excluded.

结局指标

主要结局

Disease-free survival

时间窗: More than 3 years

DFS was defined as the time interval between first treatment and recurrence or death, whichever occurred earlier.

Overall survival

时间窗: More than 3 years]

OS was defined as death related to any cause and was indexed from the date of ablation or surgery until last contact or death

次要结局

未报告次要终点

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ping Liang

Professor

Chinese PLA General Hospital

研究点 (1)

Loading locations...

相似试验